Logo

Taiwan's Chang Gung Memorial Hospital Joins Japanese Cancer Genomic Screening Project

May 31, 2019 | staff reporter

NEW YORK (GenomeWeb) — The National Cancer Center of Japan (NCC) said today that its Cancer Genomic Screening Project for Individualized Medicine (LC-SCRUM) has partnered with Chang Gung Memorial Hospital (CGMH) in Taiwan to expand its lung cancer genomic screening network.

LC-SCRUM was established in 2013 to screen target genes in lung cancer to advance the development of new drugs and diagnostics. To date, it has screened genes in over 7,000 patients in cooperation with over 200 medical institutions and pharmaceutical firms in Japan as well as with business development partner Premia.

NCC said that the addition of CGMH creates a regional cancer genomic screening network called LC-SCRUM-Asia.

Filed under

Cancer
Sequencing
Genetic Research
Drug Discovery & Development
Asia/Oceania
Lung Cancer
Breaking News
The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.